Jean-Jacques Kiladjian: Inserm Grand Est Meeting on Clinical Research at CIC Strasbourg
Jean-Jacques Kiladjian, Head of Clinical Research Department of Inserm, Professor of Medicine at the University of Paris Cité, President of the FIM, shared a post on LinkedIn:
”A beautiful day organized by Eric Simon and the regional management Inserm Grand Est around the Clinical Investigation Center CIC Strasbourg.
Explanations and in-depth discussion with Strasbourg University Hospital Center (CHRU de Strasbourg – Strasbourg University Hospitals) and the University of Strasbourg on the role of Inserm in clinical research, the specificities of a Clinical Investigation Center (CIC), the advantages of this joint label between the Directorate General for Healthcare Provision (DGOS) and Inserm, and the place of universities in this system.”
Stay updated with Hemostasis Today.
-
Jun 25, 2026, 15:28Damon Race: Pursuing Long-Term Expression in Hemophilia A Gene Therapy
-
Jun 25, 2026, 15:23Jonas Kingo: ISTH 2026 in Paris Brings the Global Hemostasis Community Together
-
Jun 25, 2026, 15:21Balancing Therapeutic Progress and Emergency Preparedness in Hemophilia – CRH French Reference Center for Hemophilia Lyon
-
Jun 25, 2026, 15:06Ifeanyichukwu Ifechidere: What If One of the Biggest Myth Fact About APS is Hidden in its Name?
-
Jun 25, 2026, 15:05Gopal Patidar: Advancing Haemovigilance and Global Collaboration at ISBT 2026
-
Jun 25, 2026, 14:52Violeta Jardin: Measuring Antifibrinolytic Effect to Improve Tranexamic Acid Safety
-
Jun 25, 2026, 14:34Heghine Khachatryan: Hemostasis at the Crossroads of Immunity and Inflammation
-
Jun 25, 2026, 14:30Jean-Jacques Kiladjian: Building the Next Generation of MPN Leaders
-
Jun 25, 2026, 14:29Shadi Tabibian: Navigating Modern Diagnosis and Individualized Care in Hemophilia A and B